Dr. Michelle Tarver, a veteran of the Food and Drug Administration (FDA), has taken charge of the FDA’s device division at a ...

Neuralink's second brain implant shows promise as the company aims to enhance the quality of life for individuals with spinal ...

The world's richest person could get a lot of help with contracts and regulatory headaches during the Trump administration.

Elon Musk’s backing of Donald Trump’s decisive victory for a second presidency gives the billionaire entrepreneur ...

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

Elon Musk’s substantial support for Donald Trump’s re-election has the potential to reshape regulatory oversight across his ...

Musk donated at least $119 million to a pro-Trump political action committee and vocally supported the former US president during the campaign’s final stretch, according to federal records.

Musk has long criticized the FDA’s approval processes, which he believes hinder innovation at Neuralink. A sympathetic ...

Michelle Tarver, MD, PhD, a 15-year veteran of the agency, is stepping into a pivotal role as the new director of the FDA's device division, taking over for Jeffrey Shuren, MD. Dr. Shuren's tenure was ...

Musk has business interests that depend heavily on government regulation, subsidies or policy, from Tesla’s electric cars to ...